Blisovi 24 Fe
These highlights do not include all the information needed to use BLISOVI 24 Fe safely and effectively. See Full Prescribing Information for BLISOVI 24 Fe. Blisovi 24 Fe [norethindrone acetate and ethinyl estradiol tablets USP, (1 mg/0.02 mg) and ferrous fumarate tablets, (75 mg)] for Oral Use Initial U.S. Approval: 1968
Approved
Approval ID
1183b048-16f3-47a4-a42f-22ba07b2bb52
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 13, 2023
Manufacturers
FDA
Lupin Pharmaceuticals, Inc.
DUNS: 089153071
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norethindrone acetate and ethinyl estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68180-864
Application NumberANDA091398
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone acetate and ethinyl estradiol
Product Specifications
Effective DateDecember 13, 2023
FDA Product Classification